Puma Biotechnology Inc. (NYSE:PBYI)

CAPS Rating: 1 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar OklaBoston (59.62) Submitted: 7/12/2015 1:00:57 AM : Underperform Start Price: $107.50 PBYI Score: +22.89

Last trade was at 11X BV and the company deficit is increasing, not shrinking.

Sounds like a short rather than a buy, doesn't it?

Recs

0
Member Avatar TMFTypeoh (84.05) Submitted: 6/24/2015 11:57:47 AM : Outperform Start Price: $124.55 PBYI Score: -32.44

Pullback could be a decent entry point. Strong inside ownership.

Recs

1
Member Avatar lookbeforeuleap (93.82) Submitted: 11/15/2014 6:58:54 PM : Outperform Start Price: $28.68 PBYI Score: +154.70

a 10 bagger from 3/13/2013

Recs

0
Member Avatar CramersSkeeDaddy (97.67) Submitted: 7/23/2014 2:04:00 PM : Underperform Start Price: $232.10 PBYI Score: +69.74

up 300% in one day, enough said. Hopefully they do cure/treat all cancer but the short squeeze will likely end soon. No or little revenue, or earnings.

Recs

0
Member Avatar dabhsar (< 20) Submitted: 6/2/2013 8:56:29 AM : Outperform Start Price: $39.55 PBYI Score: +82.68

This small Bio Tech company is onto key medicine break through.

Recs

0
Member Avatar IBDContrarian (23.48) Submitted: 4/6/2013 1:50:39 PM : Underperform Start Price: $30.95 PBYI Score: -134.19

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 1 96 -- A- NO EARN

Results 1 - 6 of 6

Featured Broker Partners


Advertisement